Disclosed is a pyrimidine compound acting on an EGFR exon 20 insertion mutation and an ERBB2 exon 20 insertion mutation or a pharmaceutically acceptable salt thereof.
申请人:CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED
公开号:US11530196B2
公开(公告)日:2022-12-20
Disclosed is a pyrimidine compound acting on an EGFR exon 20 insertion mutation and an ERBB2 exon 20 insertion mutation or a pharmaceutically acceptable salt thereof.